Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome.
Junker
J
J
Department of Neurology, Universitätsklinikum Münster, D-48129 Münster, Germany.
Haverkamp
W
W
Schulze-Bahr
E
E
Eckardt
L
L
Paulus
W
W
Kiefer
R
R
D000086:Acetazolamide / Q000627:therapeutic use*; D000293:Adolescent; D000638:Amiodarone / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008133:Long QT Syndrome / Q000188:drug therapy* / Q000235:genetics* / Q000503:physiopathology; D010245:Paralyses, Familial Periodic / Q000188:drug therapy* / Q000235:genetics*
D000889:Anti-Arrhythmia Agents; D000927:Anticonvulsants; D000638:Amiodarone; D000086:Acetazolamide